COMMUNIQUÉS West-GlobeNewswire
-
CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
27/09/2024 - 22:35 -
CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line
27/09/2024 - 22:35 -
Montreal hosts the 4th International Symposium on Arthrogryposis Multiplex Congenita (AMC)
26/09/2024 - 14:30 -
Interim results for the six months ended June 30, 2024
26/09/2024 - 14:30 -
Fortress Biotech to Participate in October 2024 Investor Conferences
26/09/2024 - 14:30 -
International Myeloma Foundation to Hold First Latin American Myeloma Network Summit in Brazil on September 28
26/09/2024 - 14:45 -
OneMedNet Announces Additional $1.7 Million Private Placement
26/09/2024 - 14:45 -
Units for Debt Settlement
26/09/2024 - 14:46 -
Hapbee Appoints Mr. Abdulla Al Zain to Board of Directors
26/09/2024 - 15:00 -
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025
26/09/2024 - 15:00 -
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
26/09/2024 - 15:00 -
Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
26/09/2024 - 15:05 -
SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
26/09/2024 - 15:05 -
Safety Shot Spins Off Caring Brands Business with Plans to Issue a Dividend to Shareholders
26/09/2024 - 15:15 -
GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
26/09/2024 - 15:15 -
Kaida BioPharma to Present at BioSparkVA Pitch Event
26/09/2024 - 15:15 -
New Research Findings Reveal Employers Who Contribute to HSAs See Double-Digit Growth in Employee Participation
26/09/2024 - 15:23 -
CannaCon Midwest Convenes in Cleveland October 2024
26/09/2024 - 15:35 -
BioNTX Announces 2024 Tech Transfer Showcase Finalists Pitch Competition at the 2024 iC³ Life Science & Healthcare Innovation Summit
26/09/2024 - 16:00
Pages